Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunoglobulin Therapy”

2,464 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,464 results

Testing effectiveness (Phase 2)Study completedNCT04165122
What this trial is testing

Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection

Who this might be right for
Herpes Genitalis
Heidelberg ImmunoTherapeutics GmbH 122
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07515469
What this trial is testing

A Prospective, Single-Arm, Exploratory Study of the Safety and Efficacy of Neoadjuvant Treatment With QL1706, an Anti-PD-1/Anti-CTLA-4 Bispecific Antibody, in Resectable Stage IB and IIA Hepatocellular Carcinoma With High Recurrence Risk

Who this might be right for
HCC - Hepatocellular CarcinomaIparomlimab and Tuvonralimab InjectionNeoadjuvant Immunotherapy
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07185269
What this trial is testing

The Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLE

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 198
Testing effectiveness (Phase 2)Study completedNCT02789254
What this trial is testing

FLYSYN in MRD Positive AML

Who this might be right for
Acute Myeloid Leukemia
Synimmune GmbH 31
Testing effectiveness (Phase 2)Looking for participantsNCT04153422
What this trial is testing

IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 Antibodies

Who this might be right for
Small Fiber NeuropathyAutoimmune Small Fiber NeuropathyInflammatory Polyneuropathy+1 more
Endeavor Health 20
Large-scale testing (Phase 3)Study completedNCT01022749
What this trial is testing

Efficacy Safety Study of Flu Vaccine in Immunodepression Patients

Who this might be right for
Inflammatory Bowel Disease (IBD)
Assistance Publique - Hôpitaux de Paris 228
Testing effectiveness (Phase 2)Study completedNCT00354978
What this trial is testing

Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer
M.D. Anderson Cancer Center 49
Testing effectiveness (Phase 2)Study completedNCT00783367
What this trial is testing

Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas

Who this might be right for
Follicular LymphomaMarginal Zone B-Cell LymphomaMALT Lymphoma+4 more
Abramson Cancer Center at Penn Medicine 50
Early research (Phase 1)Study completedNCT00084799
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer (SCLC)

Who this might be right for
Lung Cancer
Ludwig Institute for Cancer Research 10
Testing effectiveness (Phase 2)Looking for participantsNCT07063199
What this trial is testing

Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 30
Testing effectiveness (Phase 2)UnknownNCT03420014
What this trial is testing

Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)

Who this might be right for
Leiomyosarcoma
Philogen S.p.A. 114
Early research (Phase 1)Study completedNCT03443830
What this trial is testing

Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in Humans

Who this might be right for
Treatment of Acute Zika Virus Infection
Tychan Pte Ltd. 24
Post-approval studies (Phase 4)Looking for participantsNCT05520892
What this trial is testing

Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children

Who this might be right for
Newly Diagnosed Immune Thrombocytopenia in Children, First Line Treatment
Fujian Medical University Union Hospital 580
Not applicableLooking for participantsNCT05384509
What this trial is testing

(COVID-19) Longitudinal Neutralizing Antibody Titers in Cancer Patients Receiving Different Anti-caner Therapies

Who this might be right for
Cancer
Chang Gung Memorial Hospital 320
Early research (Phase 1)Study completedNCT02678338
What this trial is testing

CAMELLIA: Anti-CD47 Antibody Therapy in Haematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Gilead Sciences 20
Not applicableLooking for participantsNCT05717738
What this trial is testing

Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Tongji Hospital 300
Early research (Phase 1)Study completedNCT00005616
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center 12
Large-scale testing (Phase 3)Study completedNCT01385826
What this trial is testing

Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis

Who this might be right for
UveitisJuvenile Arthritis
Assistance Publique - Hôpitaux de Paris 34
Large-scale testing (Phase 3)Study completedNCT05093478
What this trial is testing

The Prevalence of Local Immunoglobulin E (IgE) Elevation and Its Effect on Intranasal Capsaicin Therapy in the Non-allergic Rhinitis Population

Who this might be right for
Non-allergic Rhinitis
The University of Texas Health Science Center, Houston 28
Not applicableUnknownNCT01828008
What this trial is testing

Treatment of CD20 Antibody Plus CIK for Patients With Refractory Lymphomas

Who this might be right for
Lymphomas
Han weidong 20
Load More Results